Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

BTG enters agreement with Novo Nordisk for pain and epilepsy compounds

Jan. 26, 1999

More 5-HT4 receptor ligands in development at Synthelabo

Jan. 26, 1999

Subunit-selective GABA-A receptor ligands for anxiety, convulsions reported by MS&D

Jan. 26, 1999

L-754030 will enter phase III testing for emesis

Jan. 25, 1999

Preparation and use of neuronal NOS inhibitors disclosed by Astra

Jan. 25, 1999

New 5-HT4 receptor ligands from Synthelabo, their synthesis and use

Jan. 25, 1999

Neurotransmitter reuptake-inhibitory piperidines designed at NeuroSearch

Jan. 25, 1999

Several setbacks reported with Lundbeck antipsychotic

Jan. 22, 1999

Compounds for depression and other CNS disorders reported by Akzo Nobel

Jan. 22, 1999

Ferrer selects new compound for clinical development as atypical antipsychotic

Jan. 21, 1999

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...